Basics
Description
- Primary mechanism of tricyclic antidepressant (TCA) toxicity:
- Sodium channel blocking effect (quinidine-like effect)
- Inhibition of norepinephrine reuptake
- α-blockade
- Anticholinergic effect
- Selective serotonin reuptake inhibitors (SSRIs):
- Wider margin of safety than TCA
- Less CNS/cardiovascular toxicity
- Nonselective serotonin reuptake inhibitors:
- Serotonin and norepinephrine reuptake inhibitors (SNRIs)
- Can cause cardiac dysrhythmias or seizures
- Venlafaxine (Effexor)
- See "Antidepressants, Poisoning. "
Etiology
- TCAs:
- Amitriptyline
- Nortriptyline
- Imipramine
- Doxepin
- Newer-generation antidepressants (nontricyclic):
- Have different toxic profile than TCAs
- See "Antidepressants, Poisoning. "
- Rapid deterioration may occur.
Diagnosis
Signs and Symptoms
- Rapid deterioration may occur.
- Classic TCA compounds (imipramine, amitriptyline, nortriptyline) " greatest cardiovascular toxicity
- Newer agents (serotonergic agents) " less overall toxicity in overdose
- CNS:
- Stimulation or depression
- Stimulation:
- Tremulousness
- Agitation
- Fasciculation
- Seizures (resulting acidemia may lead to worsening cardiovascular toxicity)
- Depression:
- Cardiovascular system:
- Hypotension
- Tachycardia:
- Early; owing to blockade of norepinephrine reuptake and anticholinergic effects
- Bradycardia:
- Late; owing to catecholamine depletion state
- ECG changes:
- QRS widening (>100 " 120 ms)
- Rightward shift in terminal 40 ms in frontal plane axis (R wave >3 mm in aVR)
- Dysrhythmias:
- Supraventricular tachycardia (SVT)
- Ventricular arrhythmias
- Anticholinergic effects (less common):
- Dilated pupils
- Decreased bowel sounds
- Urinary retention
History
Substance ingestion in patient with access to TCA
Physical Exam
- CNS:
- Stimulation or depression
- Cardiovascular:
- Tachycardia
- Mydriasis or midrange pupils
- Decreased bowel sounds
- Urinary retention (rare)
Essential Workup
- ECG: Factors associated with TCA poisoning:
- Sinus tachycardia (almost always present at some time after poisoning)
- QRS widening:
- >100 ms associated with seizure
- >160 ms associated with ventricular dysrhythmia
- QT prolongation
- PR prolongation
- Rightward shifting of terminal 40 ms QRS axis
- R-wave amplitude in aVR >3 mm
- Continuous cardiac monitor
Diagnosis Tests & Interpretation
Lab
- CBC
- Electrolytes, BUN, creatinine, glucose
- ABG
- Urine toxicology screen:
- TCA levels:
- Not useful
- Do not correlate well with degree of toxicity
- Qualitative screen appropriate to confirm ingestion if necessary
Imaging
Chest radiograph for aspiration pneumonia/pulmonary edema
Differential Diagnosis
- Drugs that cause coma:
- Alcohols
- Alcohol withdrawal
- Anticholinergics
- Lithium
- Phencyclidine (PCP)
- Opioids
- Phenothiazines
- Sedative hypnotics
- Salicylates
- Cardiotoxic drugs:
- Antidysrhythmics (category IA)
- Digoxin toxicity
- Sympathomimetics
- Anticholinergics
- Drugs that cause seizures:
- Alcohol withdrawal
- Anticholinergics
- Camphor
- Isoniazid
- Lindane
- Lithium
- Phenothiazines
- Sympathomimetics
- Toxic alcohols
Treatment
Pre-Hospital
- Do not be lulled into false sense of security with well-appearing patient:
- Rapid onset of altered mental status, seizures, and dysrhythmias occur.
- Perform endotracheal intubation if any evidence of compromise.
- Secure IV access.
- Administer sodium bicarbonate if any evidence of QRS widening (>100 " 120 ms):
- 1 ampule in adults
- 1 " 2 mEq/kg in children
- Ipecac contraindicated (risk for aspiration with development of depressed mental status or seizure)
Initial Stabilization/Therapy
- ABCs:
- Low threshold to intubate patients with altered mental status
- IV 0.9% normal saline (NS)
- Oxygen
- Cardiac monitor:
- For wide-complex rhythm (QRS >100 " 120 ms) bolus sodium bicarbonate
- Naloxone, thiamine, glucose (Accu-Chek) for altered mental status
- Flumazenil contraindicated in combined TCA/benzodiazepine overdose
Ed Treatment/Procedures
Cardiac Toxicity
- Initiate therapy for cardiac toxicity aggressively to prevent deterioration.
- QRS widening (>100 " 120 ms):
- Bolus with 1 amp (peds: 1 " 2 mEq/kg) of sodium bicarbonate; repeat if sudden increase in QRS width
- Maintain arterial pH of 7.45 " 7.5 with hyperventilation.
- Initiate sodium bicarbonate infusion if hyperventilation alone does not reach target pH.
- Dysrhythmia:
- Sinus tachycardia requires no treatment.
- Bolus 1 " 2 amps of sodium bicarbonate (1 " 2 mEq/kg in children) for sudden change in rhythm
- Follow advanced cardiac life support (ACLS) protocol with addition of sodium bicarbonate boluses:
- Lidocaine is 2nd-line agent after sodium bicarbonate.
- Use of class IA (procainamide) and IC agents and physostigmine contraindicated
Hypotension
- 0.9% NS fluid bolus
- Norepinephrine:
- Preferred pressor (over dopamine)
- Countersα-blockade better
- Dopamine requires higher doses.
Decontamination
- Gastric lavage:
- For recent ingestion (<1 hr)
- Performed when airway has been secured in lethargic patient
- Administer activated charcoal with sorbitol.
- Ipecac contraindicated
Seizure
- Diazepam 1st-line followed by phenobarbital
- Neuromuscular paralysis with short-acting agent (rocuronium/vecuronium) for refractory seizures (monitor EEG)
- Sodium bicarbonate bolus to prevent acidosis
Medication
First Line
- Sodium bicarbonate: 1 " 2 amps (50 " 100 mEq) IV push (peds: 1 " 2 mEq/kg)
- Activated charcoal slurry: 1 " 2 g/kg up to 90 g PO
Second Line
- Dextrose: D50W, 1 amp: 50 mL or 25 g (peds: D25W, 2 " 4 mL/kg) IV
- Diazepam (benzodiazepine): 5 " 10 mg (peds: 0.2 " 0.5 mg/kg) IV
- Dopamine: 2 " 20 Όg/kg/min IV infusion titrated to desired effect
- Intralipid fat emulsion 20%: 1.5 mL/kg IV followed by 0.25 mL/kg/min (experimental for patients refractory to bicarbonate). Call Poison Control Center for guidance.
- Lorazepam (benzodiazepine): 2 " 6 mg (peds: 0.03 " 0.05 mg/kg) IV
- Naloxone (Narcan): 2 mg (peds: 0.1 mg/kg) IV or IM initial dose
- Norepinephrine: 4 " 12 Όg/min (peds: 0.05 " 0.1 Όg/kg/min) IV infusion titrated to desired effect
Follow-Up
Disposition
Admission Criteria
- Symptomatic patients observed >6 hr
- Altered mental status
- Dysrhythmia or conduction delay
- Seizure
- Heart rate >100 beats/min 6 hr after ingestion
- Coingestion requiring prolonged observation
Discharge Criteria
- Asymptomatic after 6-hr observation
- No alteration in mental status
- Normal ECG with heart rate <100 beats/min
- Active bowel sounds; tolerated, activated charcoal
- Psychiatry clearance if there has been suicide attempt or gesture
Issues for Referral
Toxicology or poison center consultation for significant ingestions
Followup Recommendations
Psychiatry for suicide attempts
Pearls and Pitfalls
- The hallmark of TCA poisoning is rapid clinical deterioration.
- Vigilant monitoring for QRS widening beyond 120 ms is essential.
- Achieve target pH with hyperventilation in the intubated TCA overdose patient.
- Treat acute widening of the QRS beyond 120 ms with bolus bicarbonate.
Additional Reading
- Blaber MS, Khan JN, Brebner JA, et al. "Lipid rescue " for tricyclic antidepressant cardiotoxicity. J Emerg Med. 2012;3:465 " 467.
- Geis GL, Bond GR. Antidepressant overdose: Tricyclics, selective serotonin reuptake inhibitors, and atypical antidepressants. In: Erickson TB, Ahrens W, Aks SE, et al., eds. Pediatric Toxicology. New York, NY: McGraw-Hill; 2004:297 " 302.
- Reilly TH, Kirk MA. Atypical antipsychotics and newer antidepressants. Emerg Med Clin North Am. 2007;25:477 " 497.
- Woolf AD, Erdman AR, Nelson LS, et al. Tricyclic antidepressant poisoning: An evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). 2007;45:203 " 233.
See Also (Topic, Algorithm, Electronic Media Element)
Antidepressant Poisoning
Codes
ICD9
969.05 Poisoning by tricyclic antidepressants
ICD10
- T43.011A Poisoning by tricyclic antidepressants, accidental, init
- T43.014A Poisoning by tricyclic antidepressants, undetermined, init
SNOMED
- 69434005 Tricyclic antidepressant poisoning (disorder)
- 290859009 Tricyclic antidepressant poisoning of undetermined intent (disorder)